Digestive and Liver Disease
Volume 42, Issue 5 , Pages 341-347 , May 2010

Hepatocellular carcinoma in non-cirrhotic liver: A reappraisal

Received 20 July 2009 ,Accepted 11 September 2009.

References 

  1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108
  2. Okuda K, Nakashima T, Kojiro M, et al. Hepatocellular carcinoma without cirrhosis in Japanese patients. Gastroenterology. 1989;97:140–146
  3. Kew MC, Popper H. Relationship between hepatocellular carcinoma and cirrhosis. Semin Liver Dis. 1984;4:136–146
  4. Calvet X, Bruix J, Brú C, et al. Natural history of hepatocellular carcinoma in Spain. J Hepatol. 1990;10:311–317
  5. Stroffolini T, Sagnelli E, Mariano A, et al. Characteristics of hepatocellular carcinoma in Italy. J Hepatol. 1998;29:944–952
  6. Trevisani F, D’Intino PE, Caraceni P, et al. Etiologic factors and clinical presentation of hepatocellular carcinoma. Differences between cirrhotic and noncirrhotic Italian patients. Cancer. 1995;75:2220–2232
  7. Craig JR, Klatt EC, Yu M. Role of cirrhosis and the development of HCC: evidence from histologic studies and large population studies. In:  Tabor E,  Di Bisceglie AM,  Purcell RH editor. Etiology, pathology, and treatment of hepatocellular carcinoma in North America. Houston: Gulf Publishing; 1991;p. 177–190
  8. Nzeako UC, Goodman ZD, Ishak KG. Hepatocellular carcinoma in cirrhotic and noncirrhotic livers. A clinico-histopathologic study of 804 North American patients. Am J Clin Pathol. 1996;105:65–75
  9. National Coordination Group of Pathology of Liver Cancer . Relationship between hepatocellular carcinoma, liver cirrhosis, and hepatitis B: a pathological study. Natl Med J China. 1982;62:257–261
  10. Smalley SR, Moertel CG, Hilton JF, et al. Hepatoma in the noncirrhotic liver. Cancer. 1988;62:1414–1424
  11. Grazi GL, Cescon M, Ravaioli M, et al. Liver resection for hepatocellular carcinoma in cirrhotics and noncirrhotics. Evaluation of clinicopathologic features and comparison of risk factors for long-term survival and tumour recurrence in a single centre. Aliment Pharmacol Ther. 2003;17:119–129
  12. Chang CH, Chau GY, Lui WY, et al. Long-term results of hepatic resection for hepatocellular carcinoma originating from the noncirrhotic liver. Arch Surg. 2004;139:320–325
  13. Shimada M, Rikimaru T, Sugimachi K, et al. The importance of hepatic resection for hepatocellular carcinoma originating from nonfibrotic liver. J Am Coll Surg. 2000;191:531–537
  14. Kakar S, Burgart LJ, Batts KP, et al. Clinicopathologic features and survival in fibrolamellar carcinoma: comparison with conventional hepatocellular carcinoma with and without cirrhosis. Mod Pathol. 2005;18:1417–1423
  15. El-Serag HB, Davila JA. Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study. Hepatology. 2004;39:798–803
  16. Okuda K, Nakashima T, Sakamoto K, et al. Hepatocellular carcinoma arising in noncirrhotic and highly cirrhotic livers: a comparative study of histopathology and frequency of hepatitis B markers. Cancer. 1982;49:450–455
  17. Kalayci C, Johnson PJ, Davies SE, et al. Hepatitis B virus related hepatocellular carcinoma in the non-cirrhotic liver. J Hepatol. 1991;12:54–59
  18. Grando-Lemaire V, Guettier C, Chevret S, et al. Hepatocellular carcinoma without cirrhosis in the West: epidemiological factors and histopathology of the non-tumorous liver. Groupe d’Etude et de Traitement du Carcinome Hépatocellulaire. J Hepatol. 1999;31:508–513
  19. Bralet MP, Régimbeau JM, Pineau P, et al. Hepatocellular carcinoma occurring in nonfibrotic liver: epidemiologic and histopathologic analysis of 80 French cases. Hepatology. 2000;32:200–204
  20. Chen MF, Tsai HP, Jeng LB, et al. Prognostic factors after resection for hepatocellular carcinoma in noncirrhotic livers: univariate and multivariate analysis. World J Surg. 2003;27:443–447
  21. Kumar M, Kumar R, Hissar SS, et al. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case–control study of 213 hepatocellular carcinoma patients from India. J Gastroenterol Hepatol. 2007;22:1104–1111
  22. Taura K, Ikai I, Hatano E, et al. Influence of coexisting cirrhosis on outcomes after partial hepatic resection for hepatocellular carcinoma fulfilling the Milan criteria: an analysis of 293 patients. Surgery. 2007;142:685–694
  23. Farazi PA, DePinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer. 2006;6:674–687
  24. Liu CJ, Chen BF, Chen PJ, et al. Role of hepatitis B virus precore/core promoter mutations and serum viral load on noncirrhotic hepatocellular carcinoma: a case–control study. J Infect Dis. 2006;194:594–599
  25. Yuen MF, Tanaka Y, Shinkai N, et al. Risk for hepatocellular carcinoma with respect to hepatitis B virus genotype B/C, specific mutations of enhancer II/core promoter/precore regions and HBV DNA levels. Gut. 2008;57:98–102
  26. Guo X, Jin Y, Qian G, et al. Sequential accumulation of the mutations in core promoter of hepatitis B virus is associated with the development of hepatocellular carcinoma in Qidong, China. J Hepatol. 2008;49:718–725
  27. Yoshida H, Shiratori Y, Moriyama M, et al. Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy. Ann Intern Med. 1999;131:174–181
  28. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology. 2005;42:1208–1236
  29. Bruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma: conclusions of the Barcelona—2000 EASL conference. J Hepatol. 2001;35:421–430
  30. Ray RB, Meyer K, Ray R. Hepatitis C virus core protein promotes immortalization of primary human hepatocytes. Virology. 2000;271:197–204
  31. Park JS, Yang JM, Min MK. Hepatitis C virus nonstructural protein NS4B transforms NIH3T3 cells in cooperation with the Ha-ras oncogene. Biochem Biophys Res Commun. 2000;267:581–587
  32. Sakamuro D, Furukawa T, Takegami T. Hepatitis C virus nonstructural protein NS3 transforms NIH 3T3 cells. J Virol. 1995;69:3893–3896
  33. El-Refaie A, Savage K, Bhattacharya S, et al. HCV-associated hepatocellular carcinoma without cirrhosis. J Hepatol. 1996;24:277–285
  34. Liang TJ, Heller T. Pathogenesis of hepatitis C-associated hepatocellular carcinoma. Gastroenterology. 2004;127:S62–71
  35. De Mitri MS, Poussin K, Baccarani P, et al. HCV-associated liver cancer without cirrhosis. Lancet. 1995;345:413–415
  36. Makiyama A, Itoh Y, Kasahara A, et al. Characteristic of patients with chronic hepatitis C who develop hepatocellular carcinoma after a sustained response to interferon therapy. Cancer. 2004;101:1616–1622
  37. Ikeda M, Fujiyama S, Tanaka M, et al. Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C after sustained response to interferon. J Gastroenterol. 2005;40:148–156
  38. Ikeda K, Marusawa H, Osaki Y, et al. Antibody to hepatitis B core antigen and risk for hepatitis C-related hepatocellular carcinoma: a prospective study. Ann Intern Med. 2007;146:649–656
  39. Sherman M. Hepatocellular carcinoma: epidemiology, risk factors, and screening. Semin Liver Dis. 2005;25:143–154
  40. Adami HO, Hsing AW, Mclaughlin JK, et al. Alcoholism and liver cirrhosis in the etiology of primary liver cancer. Int J Cancer. 1992;51:898–902
  41. London WT, McGlynn KA. Liver cancer. In:  Schottenfeld D,  Fraumeni JF editor. Cancer epidemiology and prevention. New York: Oxford University Press; 1996;p. 772–793
  42. Reiter E, Zentek J, Razzazi E. Review on sample preparation strategies and methods used for the analysis of aflatoxins in food and feed. Mol Nutr Food Res. 2009;53:508–524
  43. Qian GS, Ross RK, Yu MC, et al. A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol Biomarkers Prev. 1994;3:3–10
  44. Ming L, Thorgeirsson SS, Gail MH, et al. Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China. Hepatology. 2002;36:1214–1220
  45. Lipshutz GS, Brennan TV, Warren RS. Thorotrast-induced liver neoplasia: a collective review. J Am Coll Surg. 2002;195:713–718
  46. Turlin B, Juguet F, Moirand R, et al. Increased liver iron stores in patients with hepatocellular carcinoma developed on a noncirrhotic liver. Hepatology. 1995;22:446–450
  47. Sorrentino P, D’Angelo S, Ferbo U, et al. Liver iron excess in patients with hepatocellular carcinoma developed on non-alcoholic steato-hepatitis. J Hepatol. 2009;50:351–357
  48. Kew MD. Pathogenesis of hepatocellular carcinoma in hereditary hemochromatosis: occurrence in noncirrhotic patients. Hepatology. 1990;11:1086–1087
  49. Deugnier YM, Guyader D, Crantock L, et al. Primary liver cancer in genetic hemochromatosis: a clinical, pathological, and pathogenetic study of 54 cases. Gastroenterology. 1993;104:228–234
  50. Zhou H, Fischer HP. Liver carcinoma in PiZ alpha-1-antitrypsin deficiency. Am J Surg Pathol. 1998;22:742–748
  51. Andersson C, Bjersing L, Lithner F. The epidemiology of hepatocellular carcinoma in patients with acute intermittent porphyria. J Intern Med. 1996;240:195–201
  52. Nakayama M, Okamoto Y, Morita T, et al. Promoting effect of citrulline in hepatocarcinogenesis: possible mechanism in hypercitrullinemia. Hepatology. 1990;11:819–823
  53. Conti JA, Kemeny N. Type Ia glycogenosis associated with hepatocellular carcinoma. Cancer. 1992;69:1320–1322
  54. Bianchi L. Glycogen storage disease I and hepatocellular tumours. Eur J Pediatr. 1993;152:S63–70
  55. Rudnick DA, Perlmutter DH. Alpha-1-antitrypsin deficiency: a new paradigm for hepatocellular carcinoma in genetic liver disease. Hepatology. 2005;42:514–521
  56. Le Bail B, Bioulac-Sage P, Arnoux R, et al. Late recurrence of a hepatocellular carcinoma in a patient with incomplete Alagille syndrome. Gastroenterology. 1990;99:1514–1516
  57. Bauman ME, Pound DC, Ulbright TM. Hepatocellular carcinoma arising in congenital hepatic fibrosis. Am J Gastroenterol. 1994;89:450–451
  58. Takayasu K, Muramatsu Y, Moriyama N, et al. Radiological study of idiopathic Budd-Chiari syndrome complicated by hepatocellular carcinoma. A report of four cases. Am J Gastroenterol. 1994;89:249–253
  59. Nzeako UC, Goodman ZD, Ishak KG. Hepatocellular carcinoma and nodular regenerative hyperplasia: possible pathogenetic relationship. Am J Gastroenterol. 1996;91:879–884
  60. Johnson FL, Feagler JR, Lerner KG, et al. Association of androgenic anabolic steroid therapy with development of hepatocellular carcinoma. Lancet. 1972;16:1273–1276
  61. Farrell GC, Joshua DE, Uren RF, et al. Androgen-induced hepatoma. Lancet. 1975;22:430–432
  62. Neuberger J, Forman D, Doll R, et al. Oral contraceptives and hepatocellular carcinoma. Br Med J. 1986;292:1355–1357
  63. Forman D, Vincent TJ, Doll R. Cancer of the liver and the use of oral contraceptives. Br Med J. 1986;292:1357–1361
  64. Irey NS, Manion WC, Taylor HB. Vascular lesions in women taking oral contraceptives. Arch Pathol. 1970;73:386–394
  65. Zucman-Rossi J, Jeannot E, Nhieu JT, et al. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology. 2006;43:515–524
  66. Bioulac-Sage P, Rebouissou S, Thomas C, et al. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology. 2007;46:740–748
  67. Hassan MM, Spitz MR, Thomas MB, et al. The association of family history of liver cancer with hepatocellular carcinoma: a case–control study in the United States. J Hepatol. 2009;50:334–341
  68. Gruner BA, DeNapoli TS, Andrews W, et al. Hepatocellular carcinoma in children associated with Gardner syndrome or familial adenomatous polyposis. J Pediatr Hematol Oncol. 1998;20:274–278
  69. Chaubert P, Gayer R, Zimmermann A, et al. Germ-line mutations of the p16INK4 (MTS1) Gene Occur in a subset of patients with hepatocellular carcinoma. Hepatology. 1997;25:1376–1381
  70. Tannapfel A, Wittekind C. Genes involved in hepatocellular carcinoma: deregulation in cell cycling and apoptosis. Virchows Arch. 2002;440:345–352
  71. Chiappini F, Gross-Goupil M, Saffroy R, et al. Microsatellite instability mutator phenotype in hepatocellular carcinoma in non-alcoholic and non-virally infected normal livers. Carcinogenesis. 2004;25:541–547
  72. Togni R, Bagla N, Muiesan P, et al. Microsatellite instability in hepatocellular carcinoma in non-cirrhotic liver in patients older than 60 years. Hepatol Res. 2009;39:266–273
  73. Xu L, Huang L, Li BK, et al. Clinicopathologic features and long-term outcomes of Chinese patients with hepatocellular carcinoma in non-cirrhotic liver. Dig Surg. 2008;25:376–382
  74. Capussotti L, Muratore A, Amisano M, et al. Liver resection for large-size hepatocellular carcinomas in 47 non-cirrhotic patients—no mortality and long-term survival. Hepatogastroenterology. 2006;53:768–772
  75. Okamura N, Yoshida M, Shibuya A, et al. Cellular and stromal characteristics in the scirrhous hepatocellular carcinoma: comparison with hepatocellular carcinomas and intrahepatic cholangiocarcinomas. Pathol Int. 2005;55:724–731
  76. Kassahun WT, Hauss J. Management of combined hepatocellular and cholangiocarcinoma. Int J Clin Pract. 2008;62:1271–1278
  77. Castells L, Vargas V, Comas P, et al. Hepatocellular carcinoma: clinical aspects, diagnosis, and survival in 140 cases. Med Clin (Barc). 1993;100:441–446
  78. Vivarelli M, Cavallari A, Bellusci R, et al. Ruptured hepatocellular carcinoma: an important cause of spontaneous haemoperitoneum in Italy. Eur J Surg. 1995;161:881–886
  79. Akriviadis EA. Hemoperitoneum in patients with ascites. Am J Gastroenterol. 1997;92:567–575
  80. Makuuchi M, Mori T, Gunven P, et al. Safety of hemihepatic vascular occlusion during resection of the liver. Surg Gynecol Obstet. 1987;164:155–158
  81. Hu RH, Lee PH, Yu SC, et al. Surgical resection for recurrent hepatocellular carcinoma: prognosis and analysis of risk factors. Surgery. 1996;120:23–29
  82. Bismuth H, Chiche L, Castaing D. Surgical treatment of hepatocellular carcinomas in noncirrhotic liver: experience with 68 liver resections. World J Surg. 1995;19:35–41
  83. Lubrano J, Huet E, Tsilividis B, et al. Long-term outcome of liver resection for hepatocellular carcinoma in noncirrhotic nonfibrotic liver with no viral hepatitis or alcohol abuse. World J Surg. 2008;32:104–109
  84. Bège T, Le Treut YP, Hardwigsen J, et al. Prognostic factors after resection for hepatocellular carcinoma in nonfibrotic or moderately fibrotic liver. A 116-case European series. J Gastrointest Surg. 2007;11:619–625
  85. Sasaki Y, Imaoka S, Masutani S, et al. Influence of coexisting cirrhosis on long-term prognosis after surgery in patients with hepatocellular carcinoma. Surgery. 1992;112:515–521
  86. Poon RT, Fan ST, Lo CM, et al. Long-term prognosis after resection of hepatocellular carcinoma associated with hepatitis B-related cirrhosis. J Clin Oncol. 2000;18:1094–1101
  87. Nagasue N, Ono T, Yamanoi A, et al. Prognostic factor and survival after hepatic resection for hepatocellular carcinoma without cirrhosis. Br J Surg. 2001;88:515–522
  88. Dupont-Bierre E, Compagnon P, Raoul JL, et al. Resection of hepatocellular carcinoma in noncirrhotic liver: analysis of risk factors for survival. J Am Coll Surg. 2005;201:663–670
  89. Laurent C, Blanc JF, Nobili S, et al. Prognostic factors and longterm survival after hepatic resection for hepatocellular carcinoma originating from noncirrhotic liver. J Am Coll Surg. 2005;201:656–662
  90. Lang H, Sotiropoulos GC, Brokalaki EI, et al. Survival and recurrence rates after resection for hepatocellular carcinoma in noncirrhotic livers. J Am Coll Surg. 2007;205:27–36
  91. Rayya F, Harms J, Bartels M, et al. Results of resection and transplantation for hepatocellular carcinoma in cirrhosis and noncirrhosis. Transplant Proc. 2008;40:933–935
  92. Sotiropoulos GC, Bockhorn M, Sgourakis G, et al. R0 liver resections for primary malignant liver tumors in the noncirrhotic liver: a diagnosis-related analysis. Dig Dis Sci. 2008;August [Epub ahead of print]
  93. Edeline J, Raoul JL, Vauleon E, et al. Systemic chemotherapy for hepatocellular carcinoma in non-cirrhotic liver: a retrospective study. World J Gastroenterol. 2009;15:713–716
  94. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334:693–699
  95. Llovet JM, Ricci S, Mazzaferro V, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008;359:378–390
  96. Craig JR, Peters RL, Edmondson HA, et al. Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinico-pathologic features. Cancer. 1980;46:372–379
  97. Pinna AD, Iwatsuki S, Lee RG, et al. Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation. Hepatology. 1997;26:877–883
  98. Okuda K. Natural history of hepatocellular carcinoma including fibrolamellar and hepato-cholangiocarcinoma variants. J Gastroenterol Hepatol. 2002;17:401–405
  99. Ruffin MT. Fibrolamellar hepatoma. Am J Gastroenterol. 1990;85:577–581
  100. Ringe B, Wittekind C, Weimann A, et al. Results of hepatic resection and transplantation for fibrolamellar carcinoma. Surg Gynecol Obstet. 1992;175:299–305
  101. Nagorney DM, Adson MA, Weiland LH, et al. Fibrolamellar hepatoma. Am J Surg. 1985;149:113–119
  102. Haas JE, Muczynski KA, Krailo M, et al. Histopathology and prognosis in childhood hepatoblastoma and hepatocarcinoma. Cancer. 1989;64:1082–1095
  103. Katzenstein HM, Krailo MD, Malogolowkin MH, et al. Fibrolamellar hepatocellular carcinoma in children and adolescents. Cancer. 2003;97:2006–2012
  104. Kakar S, Chen X, Ho C, et al. Chromosomal changes in fibrolamellar hepatocellular carcinoma detected by array comparative genomic hybridization. Mod Pathol. 2009;22:134–141
  105. Houben KW, McCall JL. Liver transplantation for hepatocellular carcinoma in patients without underlying liver disease: a systematic review. Liver Transplant Surg. 1999;5:91–95

PII: S1590-8658(09)00370-3

doi: 10.1016/j.dld.2009.09.002

Digestive and Liver Disease
Volume 42, Issue 5 , Pages 341-347 , May 2010

Article Tools

* Image Usage & Resolution